Carter Bruce L A
SEC-identified person · CIK 1225503 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Enanta Pharmaceuticals INC ENTA | Director | filed 2013 - 2026 |
| Mirati Therapeutics, Inc. mrtx | Director | filed 2016 - 2024 |
| Alsp Orchid Acquisition Corp I ALOR | Director | filed 2021 - 2021 |
| Xencor Inc XNCR | Director | filed 2013 - 2017 |
| Regulus Therapeutics Inc. RGLS | Director | filed 2012 - 2015 |
| QLT INC/BC QLTI | Director | filed 2006 - 2011 |
| Zymogenetics INC ZGEN | Director · President & CEO & Board Chair | filed 2006 - 2010 |
| Renovis INC RNVS | Director | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.